Resumes
Resumes
Jeremy Blitzer Phones & Addresses
-
868 Rosemary Ter, Sunnyvale, CA 94086 (408) 685-2924 (408) 962-0376
-
1000 Escalon Ave, Sunnyvale, CA 94085 (408) 746-5695
-
Santa Clara, CA
-
229 Brannan St, San Francisco, CA 94107 (415) 974-1560
-
Stanford, CA
-
Cincinnati, OH
-
868 Rosemary Ter, Sunnyvale, CA 94086
Work
Position:
Professional/Technical
Education
Degree:
High school graduate or higher
Business Records
Name / Title
Company / Classification
Phones & Addresses
Vice-President
Synamem Corporation
Noncommercial Research Organization
Noncommercial Research Organization
863 Mitten Rd, Burlingame, CA 94010
(650) 259-5000
(650) 259-5000
Vice-President, Principal
Synergenics LLC
Nonclassifiable Establishments · Noncommercial Research Organization · Biotech Business Development · Biotechnology Research & Development
Nonclassifiable Establishments · Noncommercial Research Organization · Biotech Business Development · Biotechnology Research & Development
1 Market St, San Francisco, CA 94105
1700 Owens St, San Francisco, CA 94158
1 Market, San Francisco, CA 94105
(415) 554-8170
1700 Owens St, San Francisco, CA 94158
1 Market, San Francisco, CA 94105
(415) 554-8170
Publications
Us Patents
Methods Of Treating Pain With Mgbg
View pageUS Patent:
8609734, Dec 17, 2013
Filed:
Jul 24, 2012
Appl. No.:
13/556948
Inventors:
John McKearn - Saint Louis MO, US
Jeremy Blitzer - San Francisco CA, US
Jeremy Blitzer - San Francisco CA, US
Assignee:
Pathdogica, LLC - Burglingame CA
International Classification:
A61K 31/155
US Classification:
514632, 514870
Abstract:
Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
Membrane-Coated Particles
View pageUS Patent:
20110097819, Apr 28, 2011
Filed:
Mar 16, 2009
Appl. No.:
12/922993
Inventors:
John T. Groves - Berkeley CA, US
Jeremy T. Blitzer - Sunnyvale CA, US
Jeremy T. Blitzer - Sunnyvale CA, US
International Classification:
G01N 33/567
US Classification:
436503
Abstract:
A membrane-coated particle composition and methods comprising a particle surrounded by a native cell membrane are disclosed. The cell membrane may contain selected receptors or binding components. At least a portion of the receptors or binding components are oriented on the membrane-coated particle in the same or similar orientation as in the native cell membrane. The membrane-coated particle(s) finds use, for example, in contexts of basic research, proteomics, drug discovery, drug delivery, medical diagnostics, and aspects of patient care.
Pharmaceutical For Oral Delivery Comprising Mgbg And Methods Of Treating Disease
View pageUS Patent:
20110112199, May 12, 2011
Filed:
Jul 16, 2010
Appl. No.:
12/837753
Inventors:
John McKearn - Saint Louis MO, US
Jeremy Blitzer - Sunnyvale CA, US
Jeremy Blitzer - Sunnyvale CA, US
Assignee:
PATHOLOGICA LLC - Burlingame CA
International Classification:
A61K 31/155
A61P 19/02
A61P 37/00
A61P 35/00
A61P 17/06
A61P 25/02
A61P 19/02
A61P 37/00
A61P 35/00
A61P 17/06
A61P 25/02
US Classification:
514632
Abstract:
Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
Controlled Release Oral Pharmaceutical Dosage Forms Comprising Mgbg
View pageUS Patent:
20120269891, Oct 25, 2012
Filed:
Jan 19, 2012
Appl. No.:
13/354076
Inventors:
John McKearn - Saint Louis MO, US
Jeremy Blitzer - Sunnyvale CA, US
Jeremy Blitzer - Sunnyvale CA, US
Assignee:
PATHOLOGICA LLC - Burlingame CA
International Classification:
A61K 9/48
A61K 31/155
A61P 29/00
C07C 281/16
A61K 31/155
A61P 29/00
C07C 281/16
US Classification:
424463, 564227, 514632
Abstract:
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
Pharmaceutical For Oral Delivery Comprising Mgbg And Methods Of Treating Disease
View pageUS Patent:
20140051765, Feb 20, 2014
Filed:
Oct 25, 2013
Appl. No.:
14/063541
Inventors:
John McKearn - Saint Louis MO, US
Jeremy Blitzer - San Francisco CA, US
Jeremy Blitzer - San Francisco CA, US
Assignee:
PATHOLOGICA LLC - Burlingame CA
International Classification:
A61K 31/155
US Classification:
514632
Abstract:
Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.